A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objectives: To compare the cost-effectiveness (CE) of the National Institute for Health and Care Excellence (NICE) 2015 and the WHO 2013 diagnostic thresholds for gestational diabetes mellitus (GDM). Setting: The analysis was from the perspective of the National Health Service in England and Wales. Participants: 6221 patients from four of the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study centres (two UK, two Australian), 6308 patients from the Atlantic Diabetes in Pregnancy study and 12 755 patients from UK clinical practice. Primary and secondary outcome measures planned: The incremental cost per quality-adjusted life year (QALY), net monetary benefit (NMB) and the probability of being cost-effective at CE thresholds of £20 000 and £30 000 per QALY. Results: In a population of pregnant women from the four HAPO study centres and using NICE-defined risk factors for GDM, diagnosing GDM using NICE 2015 criteria had an NMB of £239 902 (relative to no treatment) at a CE threshold of £30 000 per QALY compared with WHO 2013 criteria, which had an NMB of £186 675. NICE 2015 criteria had a 51.5% probability of being cost-effective compared with the WHO 2013 diagnostic criteria, which had a 27.6% probability of being cost-effective (no treatment had a 21.0% probability of being cost-effective). For women without NICE risk factors in this population, the NMBs for NICE 2015 and WHO 2013 criteria were both negative relative to no treatment and no treatment had a 78.1% probability of being cost-effective. Conclusion: The NICE 2015 diagnostic criteria for GDM can be considered cost-effective relative to the WHO 2013 alternative at a CE threshold of £30 000 per QALY. Universal screening for GDM was not found to be cost-effective relative to screening based on NICE risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“A recent review has, however, questioned the association between maternal glycaemia and subsequent cardio-metabolic outcomes in offspring in humans,(21) and a recent follow-up study failed to find evidence of a reduction in childhood obesity or metabolic dysfunction at 5 years in the offspring of women treated for mil…”
MethodMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Price, M. J., Ades, A., Soldan, K., Welton, N. J., Macleod, J., Simms, I., DeAngelis, D., Turner, K. M., & Horner, P. J. (2016) · Health Technology Assessment · doi:10.3310/hta20220 · Cited by 494
Horvath, K., Koch, K., Jeitler, K., Matyas, E., Bender, R., Bastian, H., Lange, S., & Siebenhofer, A. (2010) · BMJ · doi:10.1136/bmj.c1395 · Cited by 359
Duran, A., Sáenz, S., Torrejón, M. J., Bordiú, E., del Valle, L., Galindo, M., Perez, N., Herraiz, M. A., Izquierdo, N., Rubio, M. A., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0179 · Cited by 335
Mild gestational diabetes mellitus and long-term child health
Landon, M. B., Rice, M. M., Varner, M. W., Casey, B. M., Reddy, U. M., Wapner, R. J., Rouse, D. J., Biggio, J. R., Thorp, J. M., Chien, E. K., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2159 · Cited by 248
Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
Cited by
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Gestational diabetes: opportunities for improving maternal and child health
Saravanan, P., Magee, L. A., Banerjee, A., Coleman, M. A., Von Dadelszen, P., Denison, F., Farmer, A., Finer, S., Fox-Rushby, J., Holt, R., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30161-3 · Cited by 428
Self-citationBehboudi-Gandevani, S., Amiri, M., Bidhendi Yarandi, R., & Ramezani Tehrani, F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0406-1 · Cited by 321
Ramezani Tehrani, F., Naz, M. S. G., Yarandi, R. B., & Behboudi-Gandevani, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040666 · Cited by 34
“has been used as the first criteria for the definition of GDM; subsequently, GDM has been defined based on adverse pregnancy outcomes [11] after the Hyperglycemia and Adverse Pregnancy Outcomes’ (HAPO) study, which has shown a linear continuous association between the increasing values of maternal blood glucose and ad…”
MethodEconomic evaluations of gestational diabetes mellitus screening: a systematic review
Mo, X., Gai Tobe, R., Takahashi, Y., Arata, N., Liabsuetrakul, T., Nakayama, T., & Mori, R. (2021) · Journal of Epidemiology · doi:10.2188/jea.je20190338 · Cited by 29
Metadata
- Authors
- Jacklin, P. B., Maresh, M. J., Patterson, C. C., Stanley, K. P., Dornhorst, A., Burman-Roy, S., & Bilous, R. W.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-08
- Volume
- 7
- Issue
- 8
- Pages
- e016621
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2744175493
- Cited by
- 31
- References
- 8
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors. https://app.cochat.ai/papers/10.1136/bmjopen-2017-016621
- The paper
- Jacklin, P. B., Maresh, M. J., Patterson, C. C., Stanley, K. P., Dornhorst, A., Burman-Roy, S., & Bilous, R. W. (2017). A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors. BMJ Open. https://doi.org/10.1136/bmjopen-2017-016621
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.